Vivos Therapeutics, Inc. (28)
Browse by Contract Category
Contracts
-
Placement Agency Agreement, dated January 5, 2023, between the Company and the Placement Agents
(Filed With SEC on January 9, 2023)
-
Form of Registration Rights Agreement, dated January 5, 2023, between the Company and the Purchaser
(Filed With SEC on January 9, 2023)
-
Form of Securities Purchase Agreement, dated January 5, 2023, between the Company and the Purchaser
(Filed With SEC on January 9, 2023)
-
Form of Pre-Funded Warrant
(Filed With SEC on January 9, 2023)
-
Form of Common Stock Warrant
(Filed With SEC on January 9, 2023)
-
Sabbatical Agreement dated September 22, 2021, by and between Vivos Therapeutics, Inc. and Dr. G. Dave Singh
(Filed With SEC on September 27, 2021)
-
Representatives Warrant, dated May 11, 2021
(Filed With SEC on May 12, 2021)
-
Underwriting Agreement, dated May 6, 2021, by and between the Company and Roth, as representative of the several underwriters
(Filed With SEC on May 12, 2021)
-
Form of Representatives Warrant
(Filed With SEC on May 3, 2021)
-
Form of Underwriting Agreement
(Filed With SEC on May 3, 2021)
-
Licensing, Distribution, and Marketing Agreement dated February 12, 2021 between the Company and MyCardio, LLC
(Filed With SEC on March 25, 2021)
-
Description of Registered Securities
(Filed With SEC on March 25, 2021)
-
Underwriting Agreement, dated December 10, 2020, by and between the Company and Roth, as representative of the several underwriters
(Filed With SEC on December 15, 2020)
-
Form of Representatives Warrant, dated December 15, 2020
(Filed With SEC on December 15, 2020)
-
Form of Representatives Warrant
(Filed With SEC on November 19, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on November 19, 2020)
-
Amended and Restated Executive Employment Agreement, dated October 8, 2020, between Bradford Amman and Vivos Therapeutics, Inc
(Filed With SEC on October 26, 2020)
-
Amended and Restated Executive Employment Agreement, dated October 8, 2020, between R. Kirk Huntsman and Vivos Therapeutics, Inc
(Filed With SEC on October 26, 2020)
-
Form of Stock Certificate
(Filed With SEC on October 9, 2020)
-
Vivos Therapeutics, Inc. 2019 Stock Option and Stock Issuance Plan
(Filed With SEC on October 9, 2020)
-
Amended and Restated Executive Employment Agreement, dated October 8, 2020, between Bradford Amman and Vivos Therapeutics, Inc
(Filed With SEC on October 9, 2020)
-
Amended and Restated Executive Employment Agreement, dated October 9, 2020, between G. Dave Singh and Vivos Therapeutics, Inc
(Filed With SEC on October 9, 2020)
-
Amended and Restated Executive Employment Agreement, dated October 8, 2020, between R. Kirk Huntsman and Vivos Therapeutics, Inc
(Filed With SEC on October 9, 2020)
-
Security Agreement, dated May 6, 2017, by and between Vivos Biotechnologies, Inc. and Dr. Gurdev Dave Singh
(Filed With SEC on October 9, 2020)
-
Intellectual Property & Asset Purchase Agreement, dated May 4, 2017, by and between Vivos Biotechnologies, Inc. and Dr. Gurdev Dave Singh
(Filed With SEC on October 9, 2020)
-
Amendment to Share Exchange Agreement, dated September 15, 2016, among Vivos Therapeutics, Inc., BioModeling Solutions, Inc., shareholders of BioModeling Solutions, Inc., First...
(Filed With SEC on October 9, 2020)
-
Share Exchange Agreement, dated August 16, 2016, among Vivos Therapeutics, Inc., BioModeling Solutions, Inc., shareholders of BioModeling Solutions, Inc., First Vivos, Inc., and...
(Filed With SEC on October 9, 2020)
-
Vivos Therapeutics, Inc. 2017 Stock Option and Stock Issuance Plan
(Filed With SEC on October 9, 2020)